Segment, Customer and Geographical Reporting (Tables)

6 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The Company’s segment information for the three months ended March 31, 2016 and 2015 is summarized below:

Results of Operations for the Three Months Ended March 31,
2016
				Contract
	Optics			Research			Biomedical		Total
Revenue	$	6,428,000		$	4,868,000		$	-	$	11,296,000
Gross Profit		2,208,000			1,870,000			-		4,078,000
GM %		34.3	%		38.4	%		-		36.1	%
SG&A		1,882,000			1,800,000			355,000		4,037,000
Gain on sale of assets		-			-			-		-
Operating Income (Loss)		326,000			70,000			(355,000)		41,000
Depreciation and Amortization		225,000			85,000			17,000		327,000
Capital expenditures		329,000			30,000			20,000		379,000
Intangibles, Net		608,000			247,000			301,000		1,156,000
Goodwill		1,109,000			4,939,000			-		6,048,000
Total Assets	$	17,653,000		$	8,502,000		$	571,000	$	26,726,000

Results of Operations for the Three Months Ended March 31,
2015
				Contract
	Optics			Research			Biomedical		Total
Revenue	$	5,220,000		$	4,675,000		$	-	$	9,895,000
Gross Profit		1,808,000			1,952,000			-		3,760,000
GM %		34.6	%		41.8	%		-		38.0	%
SG&A		1,580,000			1,896,000			270,000		3,746,000
Gain on sale of assets		-			-			-		-
Operating Income (Loss)		228,000			56,000			(270,000)		14,000
Depreciation and Amortization		204,000			74,000			15,000		293,000
Capital expenditures		152,000			4,000			56,000		212,000
Intangibles, Net		699,000			282,000			254,000		1,235,000
Goodwill		1,157,000			4,939,000			-		6,096,000
Total Assets	$	16,038,000		$	8,887,000		$	694,000	$	25,619,000

The Company’s segment information for the six months ended March 31, 2016 and 2015 is summarized below:

Results of Operations for the Six Months Ended March 31,
2016
				Contract
	Optics			Research			Biomedical		Total
Revenue	$	12,635,000		$	9,858,000		$	-	$	22,493,000
Gross Profit		4,318,000			3,724,000			-		8,042,000
GM %		34.2	%		37.8	%		-		35.8	%
SG&A		3,634,000			3,506,000			703,000		7,843,000
Gain on sale of assets		(4,000)			-			-		(4,000)
Operating Income (Loss)		688,000			218,000			(703,000)		203,000
Depreciation and Amortization		454,000			164,000			34,000		652,000
Capital expenditures		894,000			37,000			51,000		982,000
Intangibles, Net		608,000			247,000			301,000		1,156,000
Goodwill		1,109,000			4,939,000			-		6,048,000
Total Assets	$	17,653,000		$	8,502,000		$	571,000	$	26,726,000

Results of Operations for the Six Months Ended March 31,
2015
				Contract
	Optics			Research			Biomedical		Total
Revenue	$	10,168,000		$	9,338,000		$	-	$	19,506,000
Gross Profit		3,302,000			4,050,000			-		7,352,000
GM %		32.5	%		43.4	%		-		37.7	%
SG&A		3,670,000			3,778,000			504,000		7,952,000
Gain on sale of assets		(185,000)			-			-		(185,000)
Operating Income (Loss)		(183,000)			272,000			(504,000)		(415,000)
Depreciation and Amortization		408,000			148,000			30,000		586,000
Capital expenditures		396,000			4,000			56,000		456,000
Intangibles, Net		699,000			282,000			254,000		1,235,000
Goodwill		1,157,000			4,939,000			-		6,096,000
Total Assets	$	16,038,000		$	8,887,000		$	694,000	$	25,619,000

Schedule Of Segment Revenue By Geographical Location [Table Text Block]

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended March 31, 2016 and 2015 are as follows:

	Three Months Ended					Three Months Ended
	March 31, 2016					March 31, 2015
Geographic Location	Revenue		% of Total			Revenue		% of Total
United States	$	8,226,000		73	%	$	7,982,000		81	%
Europe		2,452,000		22	%		1,124,000		11	%
Other		618,000		5	%		789,000		8	%
	$	11,296,000		100	%	$	9,895,000		100	%

Revenue by geographic location in total and as a percentage of total revenue, for the six months ended March 31, 2016 and 2015 are as follows:

	Six Months Ended					Six Months Ended
	March 31, 2016					March 31, 2015
Geographic Location	Revenue		% of Total			Revenue		% of Total
United States	$	16,455,000		73	%	$	15,664,000		80	%
Europe		4,493,000		20	%		2,008,000		10	%
Other		1,545,000		7	%		1,834,000		10	%
	$	22,493,000		100	%	$	19,506,000		100	%